Trace metal imaging in diagnostic of hepatic metal disease

Mass Spectrometry Reviews

Volumn 35, Issue 6, 2016, Pages 666-686

  Susnea, Iuliana ^a   Weiskirchen, Ralf ^b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

hemochromatosis; laser ablation inductively coupled plasma mass spectrometry; liver; metal bioimaging; metal poisoning; secondary ion mass spectrometry; synchrotron X ray fluorescence; Wilson's disease

Indexed keywords

ABLATION; BODY FLUIDS; CLINICAL RESEARCH; DIAGNOSIS; DISEASES; FLUORESCENCE; FLUORESCENCE MICROSCOPY; INDUCTIVELY COUPLED PLASMA; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; LASER ABLATION; LASER DIAGNOSTICS; LIVER; METABOLITES; METALS; NUTRITION; SECONDARY EMISSION; SECONDARY ION MASS SPECTROMETRY; X RAYS;

BIO-IMAGING; HEMOCHROMATOSIS; LASER ABLATION INDUCTIVELY-COUPLED PLASMA MASS SPECTROMETRIES; METAL POISONING; SYNCHROTRON X-RAY FLUORESCENCES; WILSON'S DISEASE;

TRACE ELEMENTS;

METAL;

HUMAN; LIVER; LIVER DISEASE; LOW LEVEL LASER THERAPY; SECONDARY ION MASS SPECTROMETRY;

HUMANS; LASER THERAPY; LIVER; LIVER DISEASES; METALS; SPECTROMETRY, MASS, SECONDARY ION;

EID: 84923078429     PISSN: 02777037     EISSN: 10982787     Source Type: Journal    
DOI: 10.1002/mas.21454     Document Type: Review

References (145)

1. Abdollahi M, Farshchi A, Nikfar S, Seyedifar M. 2013. Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials. J Pharm Pharm Sci 16:99–114.
2. Adams DH, Sonne C. 2013. Mercury and histopathology of the vulnerable goliath grouper, Epinephelus itajara, in U.S. waters: A multi-tissue approach. Environ Res 126:254–263.
3. Adelstein SJ, Vallee BL. 1961. Copper metabolism in man. N Engl J Med 265:892–897.
4. Ahamed M, Alsalhi MS, Siddiqui MK. 2010. Silver nanoparticle applications and human health. Clin Chim Acta 411:1841–1848.
5. Alexander J. 2007. Selenium. Novartis Found Symp 282:143–153.
6. Alexidis AN, Rekka EA, Kourounakis PN. 1994. Influence of mercury and cadmium intoxication on hepatic microsomal CYP2E and CYP3A subfamilies. Res Commun Mol Pathol Pharmacol 85:67–72.
7. Altamirano-Lozano MA, Alvarez-Barrera L, Mateos-Nava RA, Fortoul TI, Rodríguez-Mercado JJ. 2014. Potential for genotoxic and reprotoxic effects of vanadium compounds due to occupational and environmental exposures: An article based on a presentation at the 8th International Symposium on Vanadium Chemistry, Biological Chemistry, and Toxicology, Washington DC, August 15–18, 2012. J Immunotoxicol 11:19–27.
8. Anand R, Binukumar BK, Gill KD. 2011. Aluminum phosphide poisoning: An unsolved riddle. J Appl Toxicol 31:499–505.
9. Ananda S, Shaohua Z, Liang L. 2013. Fatal barium chloride poisoning: Four cases report and literature review. Am J Forensic Med Pathol 34:115–118.
10. Bandhu HK, Singh B, Garg ML, Mittal BR, Singh N, Rosenberg A, Mommsen H, Dhawan DK. 2002. Hepatoprotective role of zinc indicated by hepatobiliary clearance of 99mTc-mebrofenin in protein deficient and lead toxicant rats. Hell J Nucl Med 2:118–122.
11. Barry PS. 1975. A comparison of concentrations of lead in human tissues. Br J Ind Med. 32:119–139.
12. Barst BD, Gevertz AK, Chumchal MM, Smith JD, Rainwater TR, Drevnik PE, Hudelson KE, Hart A, Verbeck GF, Roberts AP. 2011. Laser ablation ICP-MS co-localization of mercury and immune response in fish. Environ Sci Technol 45:8982–8988.
13. Becaria A, Campbell A, Bondy SC. 2002. Aluminum as a toxicant. Toxicol Ind Health 18:309–320.
14. Becaria A, Lahiri DK, Bondy SC, Chen D, Hamadeh A, Li H, Taylor R, Campbell A. 2006. Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. J Neuroimmunol 176:16–23.
15. Becker JS. 2013. Imaging of metals in biological tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS): State of the art and future developments. J Mass Spectrom 48:255–268.
16. Becker JS, Breuer U, Hsieh H-F, Osterholt T, Kumtabtim U, Wu B, Matusch A, Caruso JA, Qin Z. 2010. Bioimaging of metals and biomolecules in mouse heart by laser ablation inductively coupled plasma mass spectrometry and secondary ion mass spectrometry. Anal Chem 82:9528–9533.
17. Becker JS, Mounicou S, Zoriy MV, Becker JS, Lobinski R. 2008. Analysis of metal-binding proteins separated by non-denaturing gel electrophoresis using matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). Talanta 76:1183–1188.
18. Becker JS, Salber D. 2010. BrainMet - Bioimaging of metals in brain and metallomics: New mass spectrometric tools in brain research. Trends Anal Chem 29:966–979.
19. Bennett J, Hahn SH. 2011. Clinical molecular diagnosis of Wilson disease. Semin Liver Dis 31:233–238.
20. Berdoukas V, Nord A, Carson S, Puliyel M, Hofstra T, Wood J, Coates TD. 2013. Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age. Am J Hematol 88:E283–E285.
21. Berholf RL. 1988. Handbook on toxicity of inorganic compounds. New York: Dekker. pp. 788–800.
22. Bersényi A, Berta E, Kádár I, Glávits R, Szilágyi M, Fekete SG. 2008. Effects of high dietary molybdenum in rabbits. Acta Vet Hung 56:41–55.
23. Boaru SG, Merle U, Uerlings R, Zimmermann A, Weiskirchen S, Matusch A, Stremmel W, Weiskirchen R. 2014a. Simultaneous monitoring of cerebral metal accumulation in an experimental model of Wilson's disease by laser ablation inductively coupled plasma mass spectrometry. BMC Neurosci 15(1):98.
24. Boaru SG, Merle U, Uerlings R, Zimmermann A, Flechtenmacher C, Willheim C, Eder E, Ferenci P, Stremmel W, Weiskirchen R. 2014b. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease. J Cell Mol Med in press DOI: 10.1111/jcmm.12497
25. Bourassa MW, Miller LM. 2012. Metal imaging in neurodegenerative diseases. Metallomics 4:721–738.
26. Camaschella C, Roetto A, Calì A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P. 2000. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25:14–15.
27. Cameron KS, Buchner V, Tchounwou PB. 2011. Exploring the molecular mechanisms of nickel-induced genotoxicity and carcinogenicity: A literature review. Rev Environ Health 26:81–92.
28. Cano-Gutiérrez G, Acevedo-Nava S, Santamaría A, Altamirano-Lozano M, Cano-Rodríguez MC, Fortoul TI. 2012. Hepatic megalocytosis due to vanadium inhalation: Participation of oxidative stress. Toxicol Ind Health 28:353–360.
29. Carlson BA, Novoselov SV, Kumaraswamy E, Lee BJ, Anver MR, Gladyshev VN, Hatfield DL. 2004. Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J Biol Chem 279:8011–8017.
30. Chadha VD, Bhalla P, Dhawan DK. 2008. Zinc modulates lithium-induced hepatotoxicity in rats. Liver Int 28:558–565.
31. Chandra RK. 1984. Excessive intake of zinc impairs immune responses. JAMA 252:1443–1446.
32. Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C. 2002. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. J Ren Nutr 12:183–189.
33. Coronado VA, Bonneville JA, Nazer H, Roberts EA, Cox DW. 2005. COMMD1 (MURR1) as a candidate in patients with copper storage disease of undefined etiology. Clin Genet 68:548–551.
34. Cousins RJ. 1986. Toward a molecular understanding of zinc metabolism. Clin Physiol Biochem 4:20–30.
35. Crichton RR, Wilmet S, Legssyer R, Ward RJ. 2002. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91:9–18.
36. Das KK, Buchner V. 2007. Effect of nickel exposure on peripheral tissues: Role of oxidative stress in toxicity and possible protection by ascorbic acid. Rev Environ Health 22:157–173.
37. de Bie P, van de Sluis B, Burstein E, Duran KJ, Berger R, Duckett CS, Wijmenga C, Klomp LW. 2006. Characterization of COMMD protein-protein interactions in NF-kappaB signalling. Biochem J 398:63–71.
38. Deitrich CL, Braukmann S, Raab A, Munro C, Pioselli B, Krupp EM, Thomas-Oates JE, Feldmann J. 2010. Absolute quantification of superoxide dismutase (SOD) using species-specific isotope dilution analysis. Anal Bioanal Chem 397:3515–3524.
39. Dhawan DK, Chadha VD. 2010. Zinc: A promising agent in dietary chemoprevention of cancer. Indian J Med Res 132:676–682.
40. Eckers A, Reimann K, Klotz LO. 2009. Nickel and copper ion-induced stress signaling in human hepatoma cells: Analysis of phosphoinositide 3′-kinase/Akt signaling. Biometals 22:307–316.
41. Edel J, Di Nucci A, Sabbioni E, Manzo L, Tonini M, Minnoia C, Candedoli S. 1991. Biliary excretion of barium in the rat. Biol Trace Elem Res 30:267–276.
42. Ek KH, Morrison GM, Lindberg P, Rauch S. 2004. Comparative Tissue distribution of metals in birds in Sweden using ICP-MS and Laser Ablation ICP-MS. Arch Environ Contam Toxicol 47:259–269.
43. Ekstrand J, Nielsen JB, Havarinasab S, Zalups RK, Söderkvist P, Hultman P. 2010. Mercury toxicokinetics–dependency on strain and gender. Toxicol Appl Pharmacol 243:283–291.
44. Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts, Van Remmen LJ, Epstein HV, Huang CJ. 2005. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24:367–380.
45. Exley C. 2009. Aluminium and medicine. In: Mercê ALR, Felcman J, Recio MAL, editors. Molecular and supramolecular bioinorganic chemistry: Applications in medical sciences. Nova Science Publishers Inc. ISBN: 978-1-60456-679-6. pp. 45–68.
46. Fahrni CJ. 2007. Biological applications of X-ray fluorescence microscopy: Exploring the subcellular topography and speciation of transition metals. Curr Opin Chem Biol 11:121–127.
47. Fanni D, Fanos V, Gerosa C, Piras M, Dessì A, Atzei A, Van EP Gibo, Faa G. 2014. Effects of iron and copper overload on the human liver: An ultrastructural study. Curr Med Chem 21:3768–3774.
48. Fatmi W, Kechrid Z, Nazıroğlu M, Flores-Arce M. 2013. Selenium supplementation modulates zinc levels and antioxidant values in blood and tissues of diabetic rats fed zinc-deficient diet. Biol Trace Elem Res 152:243–250.
49. Faustino PJ, Yang Y, Progar JJ, Brownell CR, Sadrieh N, May JC, Leutzinger E, Place DA, Duffy EP, Houn F, Loewke SA, Mecozzi VJ, Ellison CD, Khan MA, Hussain AS, Lyon RC. 2008. Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue. J Pharm Biomed Anal 47:114–125.
50. 2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol 22:266–275.
51. Fosmire GJ. 1990. Zinc toxicity. Am J Clin Nutr 51:225–227.
52. Fung MC, Bowen DL. 1996. Silver products for medical indications: Risk-benefit assessment. J Toxicol Clin Toxicol 34:119–126.
53. Gressner AM, Weiskirchen R. 2006. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med 10:76–99.
54. Hall MD, Alderden RA, Zhang M, Beale PJ, Cai ZH, Lai B, Stampfl AP, Hambley TW. 2006. The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours. J Struct Biol 155:38–44.
55. Hall MD, Dillon CT, Zhang M, Beale P, Cai ZH, Lai B, Stampfl APJ, Hambley TW. 2003. The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. J Biol Inorg Chem 8:726–732.
56. Harvey LJ, Armah CN, Dainty JR, Foxall RJ, John Lewis D, Langford NJ, Fairweather-Tait SJ. 2005. Impact of menstrual blood loss and diet on iron deficiency among women in the UK. Br J Nutr 94:557–564.
57. Hayashi H, Hattori A, Tatsumi Y, Hayashi K, Katano Y, Ueyama J, Wakusawa S, Yano M, Goto H. 2013. Various copper and iron overload patterns in the livers of patients with Wilson disease and idiopathic copper toxicosis. Med Mol Morphol 46:133–140.
58. Hayashi H, Shinohara T, Goto K, Fujita Y, Murakami Y, Hattori A, Tatsumi Y, Shimizu A, Ichiki T. 2012. Liver structures of a patient with idiopathic copper toxicosis. Med Mol Morphol 45:105–109.
59. Hirayama T, Van de Bittner GC, Gray LW, Lutsenko S, Chang CJ. 2012. Near-infrared fluorescent sensor for in vivo copper imaging in a murine Wilson disease model. Proc Natl Acad Sci USA 109:2228–2233.
60. Holbrook DJ Jr, Washington ME, Leake HB, Brubaker PE. 1975. Studies on the evaluation of the toxicity of various salts of lead, manganese, platinum, and palladium. Environ Health Perspect 10:95–101.
61. Huster D. 2010. Wilson disease. Best Pract Res Clin Gastroenterol 24:531–539.
62. Jaffe JA, Liftman C, Glickman JD. 2005. Frequency of elevated serum aluminum levels in adult dialysis patients. Am J Kidney Dis 46:316–319.
63. Johncilla M, Mitchell KA. 2011. Pathology of the liver in copper overload. Semin Liver Dis 31:239–244.
64. Johnson JL, Waud WR, Rajagopalan KV, Duran M, Beemer FA, Wadman SK. 1980. Inborn errors of molybdenum metabolism: Combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor. Proc Natl Acad Sci USA 77:3715–3719.
65. Jonas L, Fulda G, Salameh T, Schmidt W, Kröning G, Hopt UT, Nizze H. 2001. Electron microscopic detection of copper in the liver of two patients with Morbus Wilson by EELS and EDX. Ultrastruct Pathol 25:111–118.
66. Kang MY, Cho SH, Lim YH, Seo JC, Hong YC. 2013. Effects of environmental cadmium exposure on liver function in adults. Occup Environ Med 70:268–273.
67. Karayalcin S, Arcasoy A, Uzunalimoglu O. 1988. Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci 33:1096–1102.
68. Keen CL, Ensunsa JL, Watson MH, Baly DL, Donovan SM, Monaco MH, Clegg MS. 1999. Nutritional aspects of manganese from experimental studies. Neurotoxicology 20:213–223.
69. Kindness A, Sekaran CN, Feldmann J. 2003. Two-dimensional mapping of copper and zinc in liver sections by laser ablation-inductively coupled plasma mass spectrometry. Clin Chem 49:1916–1923.
70. Kinoshita H, Hori Y, Fukumoto T, Ohigashi T, Shinohara K, Hayashi Y, Ku Y. 2010. Novel assessment of hepatic iron distribution by synchrotron radiation X-ray fluorescence microscopy. Med Mol Morphol 43:19–25.
71. Klaassen CD, Liu J, Choudhuri S. 1999. Metallothionein: An intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 39:267–294.
72. Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, Sanyal AJ, Nelson JE, NASH Clinical Research Network 2012. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 55:77–85.
73. Kumar V, Bal A, Gill KD. 2009. Aluminium-induced oxidative DNA damage recognition and cell-cycle disruption in different regions of rat brain. Toxicology 264:137–144.
74. Laks DR. 2009. Assessment of chronic mercury exposure within the U.S. population, National health and nutrition examination survey, 1999–2006. Biometals 22:1999–2006.
75. Lambert D, Benhayoun S, Adjalla C, Gélot MM, Renkes P, Gérard P, Felden F, Belleville F, Gaucher P, Guéant JL, Nicolas JP. 1997. Alcoholic cirrhosis and cobalamin metabolism. Digestion 58:64–71.
76. Lansdown AB. 2006. Silver in health care: Antimicrobial effects and safety in use. Curr Probl Dermatol 33:17–34.
77. Lee J, Prohaska JR, Thiele DJ. 2001. Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc Natl Acad Sci USA 98:6842–6847.
78. Le Faouder J, Laouirem S, Alexandrov T, Ben-Harzallah S, Léger T, Albuquerque M, Bedossa P, Paradis V. 2014. Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry. Proteomics 14:965–972.
79. Liu T, He W, Yan C, Qi Y, Zhang Y. 2011. Roles of reactive oxygen species and mitochondria in cadmium-induced injury of liver cells. Toxicol Ind Health 27:249–256.
80. Liu J, Waalkes MP. 2008. Liver is a target of arsenic carcinogenesis. Toxicol Sci 105:24–32.
81. Llobet JM, Domingo JL, Gómez M, Tomás JM, Corbella J. 1987. Acute toxicity studies of aluminium compounds: Antidotal efficacy of several chelating agents. Pharmacol Toxicol 60:280–283.
82. Lobinski R, Moulin C, Ortega R. 2006. Imaging and speciation of trace elements in biological environment. Biochimie 88:1591–1604.
83. Lothian A, Hare DJ, Grimm R, Ryan TM, Masters CL, Roberts BR. 2013. Metalloproteomics: Principles, challenges, and applications to neurodegeneration. Front Aging Neurosci 5:35.
84. Mai F-D, Chen B-J, Wu L-C, Li F-Y, Chen W-K. 2006. Imaging of single liver tumor cells intoxicated by heavy metals using ToF-SIMS. Appl Surf Science 252:6809–6812.
85. Mailloux RJ, Appanna VD. 2007. Aluminum toxicity triggers the nuclear translocation of HIF-1alpha and promotes anaerobiosis in hepatocytes. Toxicol In Vitro 21:16–24.
86. Mailloux R, Lemire J, Appanna V. 2007. Aluminum-induced mitochondrial dysfunction leads to lipid accumulation in human hepatocytes: A link to obesity. Cell Physiol Biochem 20:627–638.
87. Mailloux RJ, Lemire J, Appanna VD. 2011. Hepatic response to aluminum toxicity: Dyslipidemia and liver diseases. Exp Cell Res 317:2231–2238.
88. + T cells by laser ablation inductively coupled plasma mass spectrometry. Anal Chem 85:10627–10634.
89. Matusch A, Depboylu C, Palm C, Wu B, Hoglinger GU, Schafer MK, Becker JS. 2010. Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson's disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). J Am Soc Mass Spectrom 21:161–171.
90. McCall AS, Cummings CF, Bhave G, Vanacore R, Page-McCaw A, Hudson BG. 2014. Bromine is an essential trace element for assembly of collagen IV scaffolds in tissue development and architecture. Cell 157:1380–1392.
91. Medici V, Sturniolo GC. 2008. Tetrathiomolybdate, a copper chelator for the treatment of Wilson disease, pulmonary fibrosis and other indications. IDrugs 11:592–606.
92. Mendel RR. 2013. The molybdenum cofactor. J Biol Chem 288:13165–13172.
93. Menkes JH, Alter M, Steigleder GK, Weakley DR, Sung JH. 1962. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics 29:764–779.
94. Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J. 2006. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer's disease. J Struct Biol 155:30–37.
95. Mills CF, El-Gallad TT, Bremner I. 1981. Effects of molybdate, sulfide, and tetrathiomolybdate on copper metabolism in rats. J Inorg Biochem 14:189–207.
96. M-M P, Merle U, Weiskirchen R, Becker JS. 2013a. Bioimaging of copper deposition in Wilson's diseases mouse liver by laser ablation inductively coupled plasma mass spectrometry imaging (LA-ICP-MSI). Int J Mass Spectrom 354–355: 281–287.
97. M-M P, Weiskirchen R, Gassler N, Bosserhoff AK, Becker JS. 2013b. Novel bioimaging techniques of metals by laser ablation inductively coupled plasma mass spectrometry for diagnosis of fibrotic and cirrhotic liver disorders. PLoS ONE 8(3):e58702.
98. Mukhopadhyay CK, Attieh ZK, Fox PL. 1998. Role of ceruloplasmin in cellular iron uptake. Science 279:714–717.
99. Muncie HL Jr, Campbell J. 2009. α and β thalassemia. Am Fam Physician 80:339–344.
100. Nielsen P, Fischer R, Engelhardt R, Tondüry P, Gabbe EE, Janka GE. 1995. Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol 91:827–833.
101. Neuschwander-Tetri BA. 2007. Trace elements and the liver. In: Rodés J, Benhamou JP, Rizzetto M, Reichen J, Blei A, editors. Textbook in hepatology: From basic science to clinical practice, 3rd edition, Oxford: Blackwell. pp. 233–240.
102. Nordberg GF. 2009. Historical perspectives on cadmium toxicology. Toxicol Appl Pharmacol 238:192–200.
103. Nordberg M. Nordberg GF. 2009. Toxicology and biological monitoring of metals. In: Ballantyne B, Marrs T, Syversen T, editors. General and applied toxicology, 3rd Edition (GAT3). UK: John Wiley and Sons.
104. Nygren H, Dahlén G, Malmberg P. 2014. Analysis of As- and Hg-species in metal-resistant oral bacteria, by imaging ToF-SIMS. Basic Clin Pharmacol Toxicol 115:129–133.
105. Pandey AV, Tekwani BL. 1996. Formation of haemozoin/beta-haematin under physiological conditions is not spontaneous. FEBS Lett 393:189–193.
106. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dubé MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP. 2004. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77–82.
107. Patrick L. 2006. Lead toxicity, a review of the literature. Part 1: Exposure, evaluation, and treatment. Altern Med Rev 11:2–22.
108. -/- knock-out mouse model of Wilson's disease. Mol Imaging Biol 14:70–78.
109. Peto MV. 2010. Aluminium and iron in humans: Bioaccumulation, pathology, and removal. Rejuvenation Res 13:589–598.
110. Pietrangelo A. 2010. Hereditary hemochromatosis: Pathogenesis, diagnosis, and treatment. Gastroenterology 139:393–408, 408.e1–2.
111. Piperno A. 2013. Molecular diagnosis of hemochromatosis. Expert Opin Med Diagn 7:161–177.
112. Poole RL, Pieroni KP, Gaskari S, Dixon T, Kerner JA. 2012. Aluminum exposure in neonatal patients using the least contaminated parenteral nutrition solution products. Nutrients 4:1566–1574.
113. Pourahmad J, O'Brien PJ, Jokar F, Daraei B. 2003. Carcinogenic metal induced sites of reactive oxygen species formation in hepatocytes. Toxicol In Vitro 17:803–810.
114. Prasad AS. 2013. Discovery of human zinc deficiency: Its impact on human health and disease. Adv Nutr 4:176–190.
115. Punschon T, Ricachenevsky FK, Hindt MN, Socha AL, Zuber H. 2013. Methodological approaches for using synchrotron X-ray fluorescence (SXRF) imaging as a tool in ionomics: Examples from Arabidopsis thaliana. Metallomics 5:1133–1145.
116. Qin Z, Caruso JA, Lai B, Matusch A, Becker JS. 2011. Trace metal imaging with high spatial resolution: Applications in biomedicine. Metallomics 3:28–37.
117. Qu W, Diwan BA, Reece JM, Bortner CD, Pi J, Liu J, Waalkes MP. 2005. Cadmium-induced malignant transformation in rat liver cells: Role of aberrant oncogene expression and minimal role of oxidative stress. Int J Cancer 114:346–355.
118. Raab A, Pioselli B, Munro C, Thomas-Oates J, Feldmann J. 2009. Evaluation of gel electrophoresis conditions for the separation of metal-tagged proteins with subsequent laser ablation ICP-MS detection. Electrophoresis 30:303–314.
119. Rabinowitz MB, Wetherill GW, Kopple JD. 1976. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 58:260–270.
120. th International Conference on X–ray absorption fine structure, pp. 328–330.
121. Ralle M, Lutsenko S. 2009. Quantitative imaging of metals in tissues. Biometals 22:197–205.
122. Rayman MP, Stranges S. 2013. Epidemiology of selenium and type 2 diabetes: Can we make sense of it? Free Radic Biol Med 65:1557–1564.
123. Rodríguez-Mercado JJ, Altamirano-Lozano MA. 2013. Genetic toxicology of thallium: A review. Drug Chem Toxicol 36:369–383.
124. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C. 2003. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22.
125. Rosencrantz R, Schilsky M. 2011. Wilson disease: Pathogenesis and clinical considerations in diagnosis and treatment. Semin Liver Dis 31:245–259.
126. Saïdi SA, Azaza MS, Windmolders P, van Pelt J, El-Feki A. 2013. Cytotoxicity evaluation and antioxidant enzyme expression related to heavy metals found in tuna by-products meal: An in vitro study in human and rat liver cell lines. Exp Toxicol Pathol 65:1025–1033.
127. Saxena R. 2010. Special stains in interpretation of liver biopsies. Connection 14:92–103.
128. -/- mice as a model for Wilson disease. Biochim Biophys Acta 1812:1607–1615.
129. Schwarz K, Mertz W. 1959. Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys 85:292–295.
130. Seo JH, Guillong M, Aerts M, Zajacz Z, Heinrich CA. 2011. Microanalysis of S, Cl, and Br in fluid inclusions by LA–ICP-MS. Chem Geol 284:35–44.
131. Sidhu P, Garg ML, Morgenstern P, Vogt J, Butz T, Dhawan DK. 2004. Role of zinc in regulating the levels of hepatic elements following nickel toxicity in rats. Biol Trace Elem Res 102:161–172.
132. Singh UM, Sareen P, Sengar RS, Kumar A. 2013. Plant ionomics: A newer approach to study mineral transport and its regulation. Acta Physiol Plant 35:2641–2653.
133. Solon E, Schweitzer A, Stoeckli M, Prideaux B. 2010. Autoradiography, MALDI-MS, and SIMS-MS imaging in pharmaceutical discovery and development. AAPS J 12:11–26.
134. Stacchiotti A, Lavazza A, Ferroni M, Sberveglieri G, Bianchi R, Rezzani R, Rodella LF. 2008. Effects of aluminium sulphate in the mouse liver: Similarities to the aging process. Exp Gerontol 43:330–338.
135. Stearns DM. 2000. Is chromium a trace essential metal? Biofactors 11:149–162.
136. Sullivan VK, Burnett FR, Cousins RJ. 1998. Metallothionein expression is increased in monocytes and erythrocytes of young men during zinc supplementation. J Nutr 128:707–713.
137. Sullivan JF, Jetton MM, Burch RE. 1979. A Zinc tolerance tests. J Lab Clin Med 93:485–492.
138. Villiers C, Freitas H, Couderc R, Villiers MB, Marche P. 2010. Analysis of the toxicity of gold nano particles on the immune system: Effect on dendritic cell functions. J Nanopart Res 12:55–60.
139. Waalkes MP. 2003. Cadmium carcinogenesis. Mutat Res 533:107–120.
140. Wang C, Cigliano A, Delogu S, Armbruster J, Dombrowski F, Evert M, Chen X, Calvisi DF. 2013. Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: Implications for the treatment of human liver cancer. Cell Cycle 12:1999–2010.
141. Wasmuth HE, Weiskirchen R. 2010. Pathogenesis of liver fibrosis: Modulation of stellate cells by chemokines. Z Gastroenterol 48:38–45.
142. Watanabe F, Yabuta Y, Tanioka Y, Bito T. 2013. Biologically active vitamin B12 compounds in foods for preventing deficiency among vegetarians and elderly subjects: A review. J Agric Food Chem 61:6769–6775.
143. Weksler-Zangen S, Mizrahi T, Raz I, Mirsky N. 2012. Glucose tolerance factor extracted from yeast: Oral insulin-mimetic and insulin-potentiating agent: in vivo and in vitro studies. Br J Nutr 108:875–882.
144. Yang Y, Liu H, Xiang XH, Liu FY. 2013. Outline of occupational chromium poisoning in China. Bull Environ Contam Toxicol 90:742–749.
145. Ye H, Mandal R, Catherman A, Thomas PM, Kelleher NL, Ikonomidou C, Li L. 2014. Top-down proteomics with mass spectrometry imaging: A pilot study towards discovery of biomarkers for neurodevelopmental disorders. PLoS ONE 9(4):e92831.